FDA Announces Proposed Collection of Information for Serological Tests in Blood Transfusions

Summary

The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, related to the use of serological tests to reduce the risk of Trypanosoma Cruzi infection in whole blood and blood components for transfusion. The FDA is seeking public comment on this proposed collection of information.